Effect of phenylarsine oxide on fluid phase endocytosis: further evidence for activation of the glucose transporter.
We have shown previously that insulin stimulates fluid phase endocytosis in 3T3-L1 adipocytes (Gibbs et al., 1986). Using [14C]sucrose as an endocytotic marker, we show here that phenylarsine oxide, a trivalent arsenical which binds neighboring dithiols, blocked not only insulin-stimulated fluid phase endocytosis, but basal endocytosis as well. The Ki for this process was 6 microM in the presence or absence of insulin and the time required for inhibition was less than 2.5 min, the limit of detection in our assay system. These results can be compared with the inhibitory effect of phenylarsine oxide on insulin-stimulated glucose transport. Although the Ki for insulin-stimulated transport (7 microM) was similar to that for inhibition of endocytosis, basal glucose transport was not affected by the inhibitor. Further, when cells were prestimulated with insulin causing maximal stimulation of the glucose transport rate, phenylarsine oxide induced a time-dependent reduction to the basal rate (t 1/2 of 10 min), despite the fact that endocytosis was blocked immediately. This observation suggests that if the transporter is recycled by an exocytotic/endocytotic mechanism, it is distinct from fluid-phase endocytosis/exocytosis, which is a vesicle-mediated process, and provides further evidence that the transporter may undergo intrinsic activation/inactivation which does not require vesicle movement.
Frost
S C
SC
Department of Biochemistry and Molecular Biology, University of Florida, Gainesville 32610.
Lane
M D
MD
Gibbs
E M
EM
D000273:Adipose Tissue / Q000166:cytology / Q000378:metabolism / Q000648:ultrastructure; D000818:Animals; D001152:Arsenicals / Q000494:pharmacology*; D001692:Biological Transport / Q000187:drug effects / Q000502:physiology; D002460:Cell Line; D002462:Cell Membrane / Q000187:drug effects / Q000502:physiology; D004705:Endocytosis / Q000187:drug effects* / Q000502:physiology; D005089:Exocytosis / Q000187:drug effects / Q000502:physiology; D005947:Glucose / Q000493:pharmacokinetics; D007328:Insulin / Q000494:pharmacology; D008560:Membrane Fluidity / Q000187:drug effects / Q000502:physiology; D008854:Microscopy, Electron; D009004:Monosaccharide Transport Proteins / Q000502:physiology; D051381:Rats; D013997:Time Factors
D001152:Arsenicals; D007328:Insulin; D009004:Monosaccharide Transport Proteins; C029341:oxophenylarsine; D005947:Glucose